Clinical trial
A Prospective, Multi-center Clinical Study on the Application of An Artificial Intelligence Enabled Disease Detection Software to Diabetic Retinopathy Screening Based on Fundus Images
NCT03602989 is registered in ClinicalTrials.gov with Shenzhen SiBright Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multi-center Clinical Study on the Application of An Artificial Intelligence Enabled Disease Detection Software to Diabetic Retinopathy Screening Based on Fundus Images
- Lead sponsor
- Shenzhen SiBright Co., Ltd.
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 5, 2018
- Completion date
- August 31, 2019
- Enrollment
- 1,000 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.